Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum. Scope of the Report: This report studies the Inflammatory Bowel Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Inflammatory Bowel Disease market by product type and applications/end industries. Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient's disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn's disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine. The global Inflammatory Bowel Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Inflammatory Bowel Disease. Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%. Market Segment by Companies, this report covers Bristol-Myers Squibb Company Baxter International Johnson & Johnson Sanofi-Aventis Abbott Laboratories Pluristem Therapeutics Pfizer AstraZeneca Cephalon Amgen Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Crohns disease Ulcerative colitis Market Segment by Applications, can be divided into Therapeutic Diagnostics
Table of Contents 1 Inflammatory Bowel Disease Market Overview 1.1 Product Overview and Scope of Inflammatory Bowel Disease 1.2 Classification of Inflammatory Bowel Disease by Types 1.2.1 Global Inflammatory Bowel Disease Revenue Comparison by Types (2017-2023) 1.2.2 Global Inflammatory Bowel Disease Revenue Market Share by Types in 2017 1.2.3 Crohns disease
